Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial.
about
A Proposal for Early Dosing Regimens in Heart Transplant Patients Receiving Thymoglobulin and Calcineurin InhibitionThymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression.Diagnosis and management of coronary allograft vasculopathy in children and adolescents.Blood Vessels in Allotransplantation.Medication management of cardiac allograft vasculopathy after heart transplantation.Current diagnostic and treatment strategies for cardiac allograft vasculopathy.Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An OverviewNew perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.Influence of CYP3A5 genetic variation on everolimus maintenance dosing after cardiac transplantation.Measured and not estimated glomerular filtration rate should be used to assess renal function in heart transplant recipients.The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial.Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE).Chronic kidney disease after heart transplantation: a single-centre retrospective study at Skåne University Hospital in Lund 1988-2010.Cognitive function after heart transplantation: Comparing everolimus-based and calcineurin inhibitor-based regimens.Renal protection strategies after heart transplantation.Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEART.Comparison of simplified and comprehensive methods for assessing the index of microvascular resistance in heart transplant recipients.The Past, Present and Future of Heart Transplantation.
P2860
Q26738510-A597421A-DDF2-4EBD-B1B5-EE22292467BBQ35175413-61994DA3-B9A0-43C4-A7C5-3B93B1991D70Q38300629-0F4C2210-6B0D-48D9-85B2-2131617D3639Q38390676-DC1759EB-7D7B-4B32-B313-6BA0131F09CAQ38502794-F7D0183D-ED52-4028-AE2F-58A6DE02A791Q38592122-267CB054-4129-475A-9D37-F6C064E24306Q38599972-B50ADF77-9383-4C2F-AF99-DA2F5651CD92Q38849186-0727A8EC-00C3-405D-A57E-77434179657DQ40441376-AAC1EF51-B4D0-4294-ACE8-81FBFCA183C3Q41305157-15510108-1940-4FC8-85DD-6CE4F48421B0Q41418523-D3560C8E-37EF-48A8-AD84-8F0EE98C6028Q41847223-B8EC9BBB-162A-4492-88BC-8DCEE3E47C04Q47686710-E8F4345D-CB86-413B-AE4F-DB197CABCC0FQ47972743-32891623-460F-404B-9FED-2004268F8525Q48254011-B3F59AE7-AE5E-49A2-8256-FC0FC14A4D21Q48277261-77B7F5CE-300F-418D-AD2E-69B8746518E0Q49990142-E6812855-F472-498C-BEC6-8C3D85198735Q53297951-9DDB9598-5ABE-4762-AA42-FE1AEBA90F63Q55437542-4DF91557-0545-4F04-B6A2-F352BA1449C4
P2860
Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Everolimus initiation and earl ...... ecipients: a randomized trial.
@en
Everolimus initiation and earl ...... ecipients: a randomized trial.
@nl
type
label
Everolimus initiation and earl ...... ecipients: a randomized trial.
@en
Everolimus initiation and earl ...... ecipients: a randomized trial.
@nl
prefLabel
Everolimus initiation and earl ...... ecipients: a randomized trial.
@en
Everolimus initiation and earl ...... ecipients: a randomized trial.
@nl
P2093
P2860
P50
P356
P1476
Everolimus initiation and earl ...... ecipients: a randomized trial.
@en
P2093
A K Andreassen
B Andersson
G Dellgren
G Radegran
SCHEDULE Investigators
V Sigurdardottir
P2860
P304
P356
10.1111/AJT.12809
P407
P577
2014-08-01T00:00:00Z